| NCT Number | NCT07728487 |
| Lead Sponsor | Atea Pharmaceuticals, Inc. |
| Conditions | Hepatitis E |
| Enrollment | 62 participants |
| Start Date | 2026-07-13 |
| Primary Completion | 2026-12 (estimated) |
| Study Completion | 2026-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-27 |